AtriCure, Inc. (ATRC)
27.67
-0.42
(-1.50%)
USD |
NASDAQ |
May 29, 16:00
27.69
+0.02
(+0.07%)
After-Hours: 20:00
AtriCure Cash from Investing (Quarterly) : -3.852M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -20.32B |
| Boston Scientific Corp. | -591.00M |
| AngioDynamics, Inc. | -1.507M |
| Alphatec Holdings, Inc. | -19.89M |
| Baxter International, Inc. | -133.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.996M |
| Cash from Financing (Quarterly) | -13.26M |
| Free Cash Flow | 53.64M |
| Free Cash Flow Per Share (Quarterly) | -0.16 |
| Free Cash Flow to Equity (Quarterly) | -6.26M |
| Free Cash Flow to Firm (Quarterly) | -7.481M |
| Free Cash Flow Yield | 4.03% |